Pittenger & Anderson Inc’s Abiomed Inc ABMD Stock Holding History

Pittenger & Anderson Inc’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7	Closed	-$2K	–	476
2022 Q1	$2K	Hold	7	–	–	﹤0.01%	434
2021 Q4	$3K	Hold	7	–	–	﹤0.01%	423
2021 Q3	$2K	Hold	7	–	–	﹤0.01%	424
2021 Q2	$2K	Hold	7	–	–	﹤0.01%	395
2021 Q1	$2K	Hold	7	–	–	﹤0.01%	385
2020 Q4	$2K	Hold	7	–	–	﹤0.01%	362
2020 Q3	$2K	Hold	7	–	–	﹤0.01%	352
2020 Q2	$2K	Hold	7	–	–	﹤0.01%	348
2020 Q1	$1K	Hold	7	–	–	﹤0.01%	354
2019 Q4	$1K	Hold	7	–	–	﹤0.01%	369
2019 Q3	$1K	Buy	7 +2	+40%	+$432	﹤0.01%	364
2019 Q2	$1K	Hold	5	–	–	﹤0.01%	363
2019 Q1	$1K	Hold	5	–	–	﹤0.01%	376
2018 Q4	$2K	Hold	5	–	–	﹤0.01%	352
2018 Q3	$2K	Hold	5	–	–	﹤0.01%	365
2018 Q2	$2K	Hold	5	–	–	﹤0.01%	373
2018 Q1	$1K	Buy	+5	New	+$1.27K	﹤0.01%	371

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pittenger & Anderson Inc's ABMD Position: Q2 2022 in Review

Pittenger & Anderson Inc sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 7 shares — an estimated $2K sold.

Pittenger & Anderson Inc first reported a position in ABMD in Q1 2018 and held it in 17 quarters. The position peaked at $3K in Q4 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

Pittenger & Anderson Inc reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
Pittenger & Anderson Inc sold 7 Abiomed Inc shares in Q2 2022, an estimated $2K.
Pittenger & Anderson Inc first reported a position in Abiomed Inc in Q1 2018 and held it in 17 quarters.
Pittenger & Anderson Inc's Abiomed Inc position peaked at $3K in Q4 2021.
496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2022, filed 14 Jul 2022.